Recent Trends in the Incidence and Survival of Stage 1A Pancreatic Cancer: A Surveillance, Epidemiology, and End Results Analysis.
Presenting comparative study PRO results to clinicians and researchers: beyond the eye of the beholder.
Burden of comorbidities is higher among elderly survivors of oropharyngeal cancer compared with controls.
Identifying changes in scores on the EORTC-QLQ-C30 representing a change in patients' supportive care needs.
Cancer patients' function, symptoms and supportive care needs: a latent class analysis across cultures.
Prevalence of comorbidities and effect on survival in survivors of human papillomavirus-related and human papillomavirus-unrelated head and neck cancer in the United States.
Using the EORTC-QLQ-C30 in clinical practice for patient management: identifying scores requiring a clinician's attention.
Using the EORTC-QLQ-C30 in clinical practice for patient management: identifying scores requiring a clinician’s attention.
Final results of a randomized multicenter phase II study of alvocidib, cytarabine, and mitoxantrone versus cytarabine and daunorubicin (7 + 3) in newly diagnosed high-risk acute myeloid leukemia (AML).
Feasibility and value of PatientViewpoint: a web system for patient-reported outcomes assessment in clinical practice.
Major Histocompatibility Mismatch and Donor Choice for Second Allogeneic Bone Marrow Transplantation.
Needs assessments can identify scores on HRQOL questionnaires that represent problems for patients: an illustration with the Supportive Care Needs Survey and the QLQ-C30.
Comparing Prognostic Tools for Cancer Screening: Considerations for Clinical Practice and Performance Assessment.
Obstructive Sleep Apnea and Pathological Characteristics of Resected Pancreatic Ductal Adenocarcinoma.
Clinical activity of sequential flavopiridol, cytosine arabinoside, and mitoxantrone for adults with newly diagnosed, poor-risk acute myelogenous leukemia
Multiple diseases in carrier probability estimation: Accounting for surviving all cancers other than breast and ovary in BRCAPRO.
Nested, non-parametric, correlative analysis of microarrays for heterogenous phenotype characterization.
428 - Risks and Outcomes of Cytokine Release in Haploidentical Peripheral Blood Stem Cell Transplantation.
The Effects of Four Doses of Vitamin D Supplements on Falls in Older Adults : A Response-Adaptive, Randomized Clinical Trial.
Topical Estrogen Prescription Fill Rates for Women With a History of Breast Cancer Who Are Taking Hormone Therapy.
In proportion: approaches for displaying patient-reported outcome research study results as percentages responding to treatment.
PSMA-Based [(18)F]DCFPyL PET/CT Is Superior to Conventional Imaging for Lesion Detection in Patients with Metastatic Prostate Cancer.
Phase I Clinical Trials in Acute Myeloid Leukemia: 23-Year Experience From Cancer Therapy Evaluation Program of the National Cancer Institute.
Surgical Outcomes After Pancreatic Resection of Screening-Detected Lesions in Individuals at High Risk for Developing Pancreatic Cancer.
Common variation at 2p13.3, 3q29, 7p13 and 17q25.1 associated with susceptibility to pancreatic cancer.
A multicenter analysis of GTX chemotherapy in patients with locally advanced and metastatic pancreatic adenocarcinoma.
How Does Initial TreatmentChoice Affect Short-Term and Long-TermCosts for Clinically Localized Prostate Cancer?
Integrated genomic analyses identify ARID1A and ARID1B alterations in the childhood cancer neuroblastoma.
Importance of immunoglobulin heavy chain variable region mutational status in del(13q) chronic lymphocytic leukemia.
Randomized phase II trial of cytosine arabinoside with and without the CHK1 inhibitor MK-8776 in relapsed and refractory acute myeloid leukemia.
What do these scores mean? Presenting patient-reported outcomes data to patients and clinicians to improve interpretability.
DNA METHYLATION AND BREAST CANCER IN A COHORT OF HIGH-RISK WOMEN: ASSOCIATIONS WITH CLINICAL, ENVIRONMENTAL, AND FAMILY HISTORY FACTORS.